Search | Page 41 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. 2015 Scholarships Awarded to Special Group of Young People

    ... if they should wait for the baby to be born and use the stem cells from his umbilical cord blood for a bone marrow transplant, or if ...

    Page last updated 08/14/2015 - 3:36pm.

  2. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... treated with immunosuppressive drug regimens or allogeneic stem cell transplantation. However, 20-40% of patients are ineligible for ... of more primitive bone marrow stem and progenitor cells in vitro and in animal models, suggesting it could have an impact of ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  3. Overlap Syndromes: When PNH Appears with Aplastic Anemia

    ... different reasons. In classic PNH, there is breakdown of red cells and the reticulocyte count is high, but with aplastic anemia, ... to immunotherapy, these cases should be considered for a stem cell transplant . But this only applies if this criteria is used. If ...

    Interview last updated 04/15/2015 - 9:39am.

  4. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... and cyclophosphamide , the drugs used during stem cell collection and transplant, are also approved by the FDA. Melphalan is ... <50,000/mm3, within 21 days of registration ANC <1,000 cells/mm3, within 21 days of registration Hemoglobin <8 g/dL, ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  5. Prognostic value of telomere attrition in patients with aplastic anemia

    ... markedly over past 40 years due to advances in hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST). ... protect the chromosome, when the telomeres are shorter, the cells’ chromosomes are at greater risk for damage and thus disease. Telomeres ...

    Research Review last updated 05/02/2016 - 9:25am.

  6. Clinical Trials Report for June 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... or transplantation of bone marrow or similar blood cells. This study will also help us learn whether a child's age, genetics, or ...

    Page last updated 06/18/2015 - 11:47am.

  7. Adoptive Transfer of Haplo-identical DLI for AML and MDS

    ... may be a tolerable alternative to allogeneic hematopoietic stem cell transplantation (alloHSCT) for elderly patients, the Investigator ... at a dose of 1x10^8 cluster of differentiation 3 (CD3+) cells; however, due to logistics of planning infusions with staffing, donor ...

    Clinical Trial last updated 05/03/2016 - 9:59am.

  8. MDS and MDS/MPN: Past, Present, and Future 2014 American Society of Hematology (ASH) Satellite Symposium Summary for Patients and Families

    ... form and structure of patient blood or bone marrow cells). When used alone, today’s advanced techniques to study genes ... the question Can We Cure Them? The Role of Hematopoietic Stem Cell Transplantation in MDS/MPN.   Treatments for MDS/MPN are ...

    Page last updated 03/13/2015 - 5:00pm.

  9. Clinical Trials Report for May 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... or transplantation of bone marrow or similar blood cells. This study will also help us learn whether a child's age, genetics, or ...

    Page last updated 04/28/2015 - 11:38am.

  10. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... neupogen Biological: Peripheral blood stem cell The source of stem cells for all patients will be peripheral blood stem cells (PBSC) induced and ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.